These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Neoadjuvant chemotherapy followed by surgery in lung cancer: Indian scenario. Kumar S; Saikia J; Kumar V; Malik PS; Madan K; Jain D; Bharati S Curr Probl Cancer; 2020 Jun; 44(3):100563. PubMed ID: 32265058 [TBL] [Abstract][Full Text] [Related]
3. Prognostic Factor and Clinical Outcome in Stage III Non-Small Cell Lung Cancer: A Study Based on Real-World Clinical Data in the Korean Population. Kim HC; Ji W; Lee JC; Kim HR; Song SY; Choi CM; ; Cancer Res Treat; 2021 Oct; 53(4):1033-1041. PubMed ID: 33592139 [TBL] [Abstract][Full Text] [Related]
4. Timing of Surgery after Neoadjuvant Chemoradiation in Locally Advanced Non-Small Cell Lung Cancer. Gao SJ; Corso CD; Wang EH; Blasberg JD; Detterbeck FC; Boffa DJ; Decker RH; Kim AW J Thorac Oncol; 2017 Feb; 12(2):314-322. PubMed ID: 27720827 [TBL] [Abstract][Full Text] [Related]
5. Improved survival associated with neoadjuvant chemoradiation in patients with clinical stage IIIA(N2) non-small-cell lung cancer. Koshy M; Fedewa SA; Malik R; Ferguson MK; Vigneswaran WT; Feldman L; Howard A; Abdelhady K; Weichselbaum RR; Virgo KS J Thorac Oncol; 2013 Jul; 8(7):915-22. PubMed ID: 23608815 [TBL] [Abstract][Full Text] [Related]
6. Evaluating the fate of patients who undergo resections of very large, node-negative lung cancers using the National Cancer DataBase. Liu J; Hancock JG; Moreno AC; Wang Z; Boffa DJ; Detterbeck FC; Kim AW Eur J Cardiothorac Surg; 2016 Feb; 49(2):596-601. PubMed ID: 25890936 [TBL] [Abstract][Full Text] [Related]
7. Optimizing Survival of Patients With Marginally Operable Stage IIIA Non-Small-Cell Lung Cancer Receiving Chemoradiotherapy With or Without Surgery. Yang KL; Chang YC; Ko HL; Chi MS; Wang HE; Hsu PS; Lin CC; Yeh DY; Kao SJ; Jiang JS; Chi KH Clin Lung Cancer; 2016 Nov; 17(6):550-557. PubMed ID: 27378175 [TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in neoadjuvant treatment followed by surgery in stage IIIA-N2 non-small cell lung cancer: a multi-institutional study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society). Couñago F; Montemuiño S; Martin M; Taboada B; Calvo-Crespo P; Samper-Ots MP; Alcántara P; Corona J; López-Guerra JL; Murcia-Mejía M; López-Mata M; Jové-Teixidó J; Chust M; Díaz-Díaz V; de Ingunza-Barón L; García-Cañibano T; Couselo ML; Del Cerro E; Moradiellos J; Amor S; Varela A; Puertas MM; Thuissard IJ; Sanz-Rosa D; de Dios NR Clin Transl Oncol; 2019 Jun; 21(6):735-744. PubMed ID: 30430394 [TBL] [Abstract][Full Text] [Related]
9. Gender, Age, and Comorbidity Status Predict Improved Survival with Adjuvant Chemotherapy Following Lobectomy for Non-small Cell Lung Cancers Larger than 4 cm. Sandler BJ; Wang Z; Hancock JG; Boffa DJ; Detterbeck FC; Kim AW Ann Surg Oncol; 2016 Feb; 23(2):638-45. PubMed ID: 26474557 [TBL] [Abstract][Full Text] [Related]
10. Lymph node harvest in esophageal cancer after neoadjuvant chemoradiotherapy. Shridhar R; Hoffe SE; Almhanna K; Weber JM; Chuong MD; Karl RC; Meredith K Ann Surg Oncol; 2013 Sep; 20(9):3038-43. PubMed ID: 23625142 [TBL] [Abstract][Full Text] [Related]
11. Treatment patterns and clinical outcomes of patients with resectable non-small cell lung cancer receiving neoadjuvant immunochemotherapy: A large-scale, multicenter, real-world study (NeoR-World). Yang Z; Wang S; Yang H; Jiang Y; Zhu L; Zheng B; Fu H; Ma J; Xie H; Wang Z; He H; Xia C; Li R; Xu J; Han J; Huang X; Li Y; Zhao B; Ni C; Xing H; Chen Y; Wang J; Jiang Y; Song Y; Mao Y; Chen C; Yao F; Zhang G; Hu J; Xue Q; Gao S; He J; J Thorac Cardiovasc Surg; 2024 Oct; 168(4):1245-1258.e17. PubMed ID: 38342430 [TBL] [Abstract][Full Text] [Related]
12. Population-based patterns of treatment and survival for patients with stage I and II non-small cell lung cancer aged 65-74 years and 75 years or older. Driessen E; Detillon D; Bootsma G; De Ruysscher D; Veen E; Aarts M; Janssen-Heijnen M J Geriatr Oncol; 2019 Jul; 10(4):547-554. PubMed ID: 30876833 [TBL] [Abstract][Full Text] [Related]
13. Survival disparities following surgery among patients with different histological types of non-small cell lung cancer. Grosu HB; Manzanera A; Shivakumar S; Sun S; Noguras Gonzalez G; Ost DE Lung Cancer; 2020 Feb; 140():55-58. PubMed ID: 31865279 [TBL] [Abstract][Full Text] [Related]
14. Histopathologic response criteria predict survival of patients with resected lung cancer after neoadjuvant chemotherapy. Pataer A; Kalhor N; Correa AM; Raso MG; Erasmus JJ; Kim ES; Behrens C; Lee JJ; Roth JA; Stewart DJ; Vaporciyan AA; Wistuba II; Swisher SG; J Thorac Oncol; 2012 May; 7(5):825-32. PubMed ID: 22481232 [TBL] [Abstract][Full Text] [Related]
15. Computed tomography RECIST assessment of histopathologic response and prediction of survival in patients with resectable non-small-cell lung cancer after neoadjuvant chemotherapy. William WN; Pataer A; Kalhor N; Correa AM; Rice DC; Wistuba II; Heymach J; Lee JJ; Kim ES; Munden R; Gold KA; Papadimitrakopoulou V; Swisher SG; Erasmus JJ; J Thorac Oncol; 2013 Feb; 8(2):222-8. PubMed ID: 23287849 [TBL] [Abstract][Full Text] [Related]